Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05088382
Other study ID # PROTOCOL-1339
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 4, 2021
Est. completion date November 3, 2021

Study information

Verified date November 2021
Source SPD Development Company Limited
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will assess the usability of a Period Tracker product when used by lay users in their own homes.


Recruitment information / eligibility

Status Completed
Enrollment 126
Est. completion date November 3, 2021
Est. primary completion date November 3, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Female - Aged 18 to 45 years - Menstrual cycles are 21-60 days long - Seeking to predict when her next period will start - Seeking to give informed consent and comply with the investigational procedures - Has a compatible iPhone with internet access that they are willing to use for the study (iPhone 7+ and iOS 13 and above) Exclusion Criteria: - Currently pregnant or breastfeeding - Used Clearblue® me (Period Tracker app), Persona Contraception Monitor or Clearblue Advanced Fertility Monitor within the last six months - Currently or previously employed by SPD, Abbott, Alere, Unipath, P&G or affiliates - Has an immediate* relative currently or previously (within past 5 years) employed by SPD, Abbott, Alere, Unipath or P&G, or affiliates - Is a qualified or trainee healthcare professional (HCP) - Has professional experience of using dipstick type tests or lateral flow devices - Using any treatment which may affect the menstrual cycle (e.g. contraceptive pill) - Using hormone replacement medications containing LH or hCG (e.g. Pregnyl®) - Is currently seeking to conceive - Has been diagnosed with polycystic ovarian syndrome (PCOS) - Has PCOS symptoms e.g. very irregular cycles, hirsutism *Immediate relatives are defined as parents, children, siblings or partner/spouse

Study Design


Related Conditions & MeSH terms


Intervention

Device:
LH Urine Test
Test for the qualitative measurement of LH in urine

Locations

Country Name City State
United Kingdom SPD Development Company Ltd Bedford Bedfordshire

Sponsors (1)

Lead Sponsor Collaborator
SPD Development Company Limited

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Usability of the Period Tracker device when used at home Number of users scoring 3 or less on a 7 point Likert scale for various questions related to usability of the Period Tracker device after use at home 28 days (approximately 1 menstrual cycle)
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04595760 - Factors Influencing Fertility or Pregnancy Health
Completed NCT05091658 - Period Tracker Lay User Study
Completed NCT04756739 - Menstrual Cycle Symptom Tracking